Pretomanid is the first TB medicine to be developed and licensed by a not-for-profit entity. As a product development partnership, TB Alliance collaborated with and received support from governments, academia, philanthropic institutions, and a commercial partner.
Breakthrough In Fight Against Multi-Resistant Tuberculosis
